Table 1 Baseline characteristics of 17 pts with HCM
Clinical parameters | |
|---|---|
Patients, n | 17 |
Males/Females, n (%) | 9 (53%)/8(47%) |
Age (years-mean ± SD) | 53 ± 16 |
NYHA II, n (%) | 14 (82%) |
NYHA III, n (%) | 3 (18%) |
Therapy, n (%) | |
Beta-blocker | 11 (65%) |
Calcium antagonist | 4 (23%) |
Beta-blocker and calcium antagonist | 2 (12%) |
Echocardiographic parameters (LLD) | |
LVOT gradient > 30 mmHg at rest, n (%) | 11 (65%) |
Mitral regurgitation at rest, n (%) | 9 (53%) |
Left ventricular end diastolic diameter (mm) | 47 ± 4 |
Left ventricular end systolic diameter (mm) | 29 ± 4 |
Interventricular septum thickness (mm) | 17 ± 4,1 |
Posterior wall thickness (mm) | 9 ± 2,4 |
Fractional shortening (%) | 37 ± 5 |